IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Aarti Drugs

NSE:AARTIDRUGS · ISIN INE767A01016

Close
₹411.25
29 Jul 2026
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Aarti Drugs

Ratings & risks

Credit signals

Rating-action history

Agency evidence
ICRA Limited · Aarti Drugs Limited: Ratings reaffirmedICRA Limited · PDF preserved by IndiaTicker
Archived PDF
ICRA Limited · Aarti Drugs Limited: Ratings reaffirmed; rated amount enhancedICRA Limited · discovered
Agency source
ICRA Limited · Aarti Drugs Limited: Ratings reaffirmed; rated amount enhancedICRA Limited · discovered
Agency source
ICRA Limited · Aarti Drugs Limited: Ratings reaffirmed for existing limits and assigned to enhanced limitsICRA Limited · discovered
Agency source
ICRA Limited · Aarti Drugs Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Aarti Drugs Limited: Rating Withdrawn for CP ProgrammeICRA Limited · discovered
Agency source
ICRA Limited · Aarti Drugs Limited: Ratings reaffirmed; rated amount enhancedICRA Limited · discovered
Agency source
ICRA Limited · Aarti Drugs Limited: Ratings assignedICRA Limited · discovered
Agency source
CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source
CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source
CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source
CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source
CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source
ICRA Limited · ICRA withdraws ratings for bank facilities of Aarti Drugs LimitedICRA Limited · discovered
Agency source
ICRA Limited · ICRA reaffirms ratings of [ICRA]A-(Stable)/[ICRA]A2+ for bank facilities of Aarti Drugs Limited, (Issuer Not Co-operating)*ICRA Limited · discovered
Agency source
Risk research framework

Questions to test against evidence

Analyst review
Operating deterioration

Track sector-specific operating metrics and reconcile them across reporting periods.

High
Funding and liquidity

Review debt maturity, repricing, liquidity and rating commentary where relevant.

High
Execution versus guidance

Compare management statements with subsequent reported delivery.

Medium
Governance and key-person change

Connect management transitions, related parties and auditor observations.

Medium